All News Pivotal Therapeutics Inc.

Equities

PVTTF

CA72582E1043

Market Closed - OTC Markets Other stock markets 01:47:54 24/03/2023 am IST			5-day change	1st Jan Change
0.0018 ^USD	+1,79,900.00%		-.--%	-.--%

2016	Pivotal Therapeutics Inc. Announces Management Changes	CI
2015	Ford Teams with Pivotal to Speed Development of Connected Car Experiences Capitalizing on New Ford Sync Connect	CI

All News

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Pivotal Therapeutics Inc. Announces Management Changes	07/16/07	CI
Ford Teams with Pivotal to Speed Development of Connected Car Experiences Capitalizing on New Ford Sync Connect	16/15/16	CI
Pivotal Therapeutics Inc. Executes International Distribution Agreement with Healthcore Co. Ltd	30/15/30	CI
Pivotal Therapeutics Inc. Announces Earnings Results for the Nine Months Ended September 30, 2015	30/15/30	CI
Pivotal Therapeutics Inc. announced that it has received CAD 0.1 million in funding	27/15/27	CI
Pivotal Therapeutics Inc. announced that it expects to receive CAD 1.58 million in funding	05/15/05	CI
Pivotal Therapeutics Inc. Announces Financial Results for the Six Months Ended June 30, 2015	29/15/29	CI
Pivotal Therapeutics Inc. cancelled the transaction announced on June 29, 2015	28/15/28	CI
Pivotal Therapeutics Inc. announced that it expects to receive CAD 1.54 million in funding	29/15/29	CI
Pivotal Therapeutics Inc. Announces the Enrollment of the First Patient in Pivotal's POMEGA Phase IIa Clinical Trial with PVT-100	05/15/05	CI
Pivotal Therapeutics Inc. Announces Audited Consolidated Earnings Results for the Three Months Ended March 31, 2015	03/15/03	CI
Pivotal Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2014	01/15/01	CI
Pivotal Therapeutics Inc. Auditor Raises 'Going Concern' Doubt	30/15/30	CI
Pivotal Therapeutics Inc. Receives Health Canada Approval to Expand the Indication of Omazen	27/15/27	CI
Pivotal Therapeutics Inc. Executes Memorandum of Understanding for Distribution of Benefishial Line of Products in Korea	15/15/15	CI
Pivotal Therapeutics Inc. Receives Final Approval for Phase IIa Clinical Trial with PVT-100	28/15/28	CI
Pivotal Therapeutics Inc. Announces Earnings Results for the Three Months Ended September 30, 2014	29/14/29	CI
Pivotal Therapeutics Inc. Announces Resignation of Prakash Gowd as CFO	15/14/15	CI
Pivotal Therapeutics Inc. Announces Publication of Results of a Prospective Randomized Controlled Trial in the U.S	10/14/10	CI
Pivotal Therapeutics Inc. Announces Management Changes	08/14/08	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News Pivotal Therapeutics Inc.

Equities

PVTTF

CA72582E1043

All News

Filters